Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 90

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Multicenter, Double-Blind, Placebo-Controlled Study of Mecamylamine Monotherapy for Tourette's Disorder

SILVER, ARCHIE A., SHYTLE, R. DOUGLAS, SHEEHAN, KATHY H., SHEEHAN, DAVID V., RAMOS, AMAYA, SANBERG, PAUL R. · 2001 · Journal of the American Academy of Child & Adolescent Psychiatry

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00004583-200109000-00020

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 36

  1. Banerjee, 1990, [3H]Mecamylamine binding to rat brain membranes: studies with mecamylamine and nicotine analogues, Biochem Pharmacol, 40, 2105, 10.1016/0006-2952(90)90241-C · DOI
  2. Budman, 1998, Rage attacks in children and adolescents with Tourette's disorder: a pilot study, J Clin Psychiatry, 59, 576, 10.4088/JCP.v59n1103 · DOI
  3. Chappell, 1997, Future therapies of Tourette syndrome, Neurol Clin, 15, 429, 10.1016/S0733-8619(05)70324-8 · DOI
  4. Coffey, 2000, Distinguishing illness severity from tic severity in children and adolescents with Tourette's disorder, J Am Acad Child Adolesc Psychiatry, 39, 556, 10.1097/00004583-200005000-00008 · DOI
  5. Coffey, 1997, Behavioral and emotional aspects of Tourette syndrome, Neurol Clin, 15, 277, 10.1016/S0733-8619(05)70312-1 · DOI
  6. Collins, 1996, Long-term ethanol and nicotine treatment elicit tolerance to ethanol, Alcohol Clin Exp Res, 20, 990, 10.1111/j.1530-0277.1996.tb01936.x · DOI
  7. Dursun, 1995, Differential effects of transdermal nicotine patch on the symptoms of Tourette's syndrome, Br J Clin Pharmacol, 39, 100P
  8. Dursun, 1997, Differential effects of transdermal nicotine on microstructured analyses of tics in Tourette's syndrome: an open study, Psychol Med, 27, 483, 10.1017/S0033291796003984 · DOI
  9. Dursun, 1994, Longlasting improvement of Tourette's syndrome with transdermal nicotine (letter), Lancet, 344, 1577, 10.1016/S0140-6736(94)90388-3 · DOI
  10. Fulop, 1987, ECG changes during haloperidol and pimozide treatment of Tourette's disorder, Am J Psychiatry, 144, 673, 10.1176/ajp.144.5.673 · DOI
  11. Goetz, 1992, Clonidine and clonazepam in Tourette syndrome, Adv Neurol, 58, 245
  12. Goyette, 1978, Normative data on revised Conners Parent and Teacher Rating Scales, J Abnorm Child Psychol, 6, 221, 10.1007/BF00919127 · DOI · Paper page
  13. Horrigan, 1999, Guanfacine and secondary mania in children, J Affect Disord, 54, 309, 10.1016/S0165-0327(98)00183-9 · DOI
  14. Leckman, 1991, Clonidine treatment of Gilles de la Tourette's syndrome, Arch Gen Psychiatry, 48, 324, 10.1001/archpsyc.1991.01810280040006 · DOI · Paper page
  15. Leckman, 1989, The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity, J Am Acad Child Adolesc Psychiatry, 28, 566, 10.1097/00004583-198907000-00015 · DOI · Paper page
  16. Levin, 1999, Mutually potentiating effects of mecamylamine and haloperidol in producing catalepsy in rats, Drug Dev Res, 47, 90, 10.1002/(SICI)1098-2299(199906)47:2<90::AID-DDR4>3.0.CO;2-5 · doi:10.1002/(sici)1098-2299(199906)47:2<90::aid-ddr4>3.0.co;2-5
  17. Lukas, 1996, Regulation by nicotine of its own receptors, Drug Dev Res, 38, 136, 10.1002/(SICI)1098-2299(199607/08)38:3/4<136::AID-DDR2>3.0.CO;2-N · DOI
  18. Martin, 1993, Central actions of nicotine antagonists, Med Chem Res, 2, 564
  19. McConville, 1992, The effects of nicotine plus haloperidol compared to nicotine only and placebo nicotine only in reducing tic severity and frequency in Tourette's disorder, Biol Psychiatry, 31, 832, 10.1016/0006-3223(92)90315-Q · DOI
  20. Nolan, 1996, Associated psychopathology in children with both ADHD and chronic tic disorder, J Am Child Adolesc Psychiatry, 35, 1622, 10.1097/00004583-199612000-00014 · DOI
  21. Roth, 1972, Studies in the classification of affective disorders: the relationship between anxiety states and depressive illnesses, I, Br J Psychiatry, 121, 147, 10.1192/bjp.121.2.147 · DOI · Paper page
  22. Sanberg, 1989, Nicotine potentiates the effects of haloperidol in animals and in patients with Tourette syndrome, Biomed Pharmacother, 43, 19, 10.1016/0753-3322(89)90186-8 · DOI
  23. Sanberg, 1998, Treatment of Tourette's syndrome with mecamylamine (letter), Lancet, 352, 705, 10.1016/S0140-6736(05)60822-7 · DOI
  24. Sanberg, 1997, Nicotine for the treatment of Tourette's syndrome, Pharmacol Ther, 74, 21, 10.1016/S0163-7258(96)00199-4 · DOI
  25. Sandor, 1990, Tourette syndrome: a follow-up study, J Clin Psychopharmacol, 10, 197, 10.1097/00004714-199006000-00007 · DOI
  26. Shapiro, 1989, Controlled study of haloperidol, pimozide, and placebo for the treatment of Gilles de la Tourette's syndrome, Arch Gen Psychiatry, 46, 722, 10.1001/archpsyc.1989.01810080052006 · DOI · Paper page
  27. Sheehan, 1998, The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10., J Clin Psychiatry, 59, 22
  28. Shytle, 1996, Transdermal nicotine for Tourette's syndrome, Drug Dev Res, 38, 290, 10.1002/(SICI)1098-2299(199607/08)38:3/4<290::AID-DDR18>3.0.CO;2-2 · DOI
  29. Silva, 1996, Causes of haloperidol discontinuation in patients with Tourette's disorder: management and alternatives, J Clin Psychiatry, 57, 129
  30. Silver, 1996, Case study: long-term potentiation of neuroleptics with transdermal nicotine in Tourette's syndrome, J Am Acad Child Adolesc Psychiatry, 35, 1631, 10.1097/00004583-199612000-00015 · DOI
  31. Silver, 1999, Clinical experience with transdermal nicotine patch in Tourette's syndrome, CNS Spectr, 4, 68, 10.1017/S1092852900011408 · DOI
  32. Silver, 2000, Mecamylamine in Tourette's syndrome: a two-year retrospective case, J Child Adolesc Psychopharmacol, 10, 59, 10.1089/cap.2000.10.59 · DOI
  33. Silver AA, Shytle RD, Wilkinson B, McConville B, Sanberg PR (in press), Transdermal nicotine and haloperidol in Tourette syndrome: a double-blind placebo controlled study. J Clin Psychiatry
  34. Singer, 1989, Development of behavioral and emotional problems in Tourette syndrome, Pediatr Neurol, 5, 41, 10.1016/0887-8994(89)90008-8 · DOI
  35. Spencer, 1998, Disentangling the overlap between Tourette's disorder and ADHD, J Child Psychol Psychiatry, 39, 1037, 10.1111/1469-7610.00406 · doi:10.1111/1469-7610.00406 · Paper page
  36. Stone, 1956, Ganglionic blocking properties of 3-methylaminoisocamphane hydrochloride (mecamylamine): a secondary amine, J Pharmacol, 117, 169

Cited by

See all 90

Metadata

Authors
SILVER, A. A., SHYTLE, R. D., SHEEHAN, K. H., SHEEHAN, D. V., RAMOS, A., & SANBERG, P. R.
Venue
Journal of the American Academy of Child & Adolescent Psychiatry
Publisher
Elsevier BV
Published
2001-09
Volume
40
Issue
9
Pages
1103-1110
ISSN
0890-8567
Cited by
90
References
3
Language
en
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Multicenter, Double-Blind, Placebo-Controlled Study of Mecamylamine Monotherapy for Tourette's Disorder. https://app.cochat.ai/papers/10.1097/00004583-200109000-00020
The paper
SILVER, A. A., SHYTLE, R. D., SHEEHAN, K. H., SHEEHAN, D. V., RAMOS, A., & SANBERG, P. R. (2001). Multicenter, Double-Blind, Placebo-Controlled Study of Mecamylamine Monotherapy for Tourette's Disorder. Journal of the American Academy of Child & Adolescent Psychiatry. https://doi.org/10.1097/00004583-200109000-00020

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.